erythrosine has been researched along with sirolimus in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Michnick, SW; Remy, I | 1 |
| Dong, Y; Fechner, J; Feng, P; Hamawy, M; Hu, H; Knechtle, SJ | 1 |
| Burakoff, SJ; Hafler, DA; Lim, DG; Slavik, JM | 1 |
| Rensing, NR; Wong, M; Zeng, LH | 1 |
| Bhandaru, M; Bobbala, D; Lang, F; Pasham, V; Rotte, A; Zelenak, C | 1 |
| Bae, YS; Kim, JJ; Park, JH | 1 |
| Blazar, BR; Harvey, RD; Kean, LS; Kirk, AD; Larsen, CP; Singh, K; Stempora, L | 1 |
| Andersson, BS; Hassan, M; Valdez, BC | 1 |
| Al Mamun Bhuyan, A; Cao, H; Lang, F | 1 |
| Abe, K; Ait-Oufella, H; Alacamli, G; Alacamli, OG; Amir, O; Antar, S; Ashour, H; Azimonti, G; Baba, Y; Balogun, MM; Bampidis, V; Bastos, ML; Ben Hamouda, N; Bickel Haase, T; Bjornsson, R; Bostan, M; Braik, R; Brantom, P; Briggs, S; Bujor, I; Canbek, TD; Cherecheanu, AP; Chesson, A; Choudhary, RJ; Christensen, H; Chung, HR; Clavier, T; Dahman, NBH; Dani, S; Demailly, Z; Devine, LD; Ding, G; Duan, X; Durjava, M; Dusemund, B; Edebali, S; Elbaz Greener, G; Elnoby, AS; Fang, Q; Fares, AM; Fashola, MB; Fawzy, MS; Fouad, FM; Fu, SZ; Fujita, S; Furusawa, S; Gallagher, AM; Gao, J; Goyal, N; Guo, J; Hamuda, N; Han, Y; Hariri, G; Heist, EK; Hill, AJ; Homoud, M; Hu, Q; Hu, Z; Huang, L; Ide, T; Ikeda, M; Ishimaru, K; Jiang, C; Kaderli, ST; Kanamura, T; Karalezli, A; Kaur, P; Kazatsker, M; Kobo, O; Kouba, M; Kumar, R; Lavillegrand, JR; Leshem, E; Li, A; Li, S; Liu, R; López Puente, S; López-Alonso, M; Ma, M; Madias, C; Manini, P; Marcon, F; Margolis, G; Matsushima, S; Mayo, B; Miller, JE; Miyake, R; Miyamoto, HD; Naumann-Gola, S; Ortner, E; Pandit, R; Pang, Y; Pechová, A; Petkova, M; Pîrvulescu, R; Popa-Cherecheanu, A; Ramos, F; Roguin, A; Rozen, G; Ruskin, JN; Sanz, Y; Schweiggert-Weisz, U; Shafie, AAA; Sharma, H; Shi, X; Stoicescu, EA; Stopyra, W; Suh, JD; Sul, S; Tamion, F; Tiu, C; Tohyama, T; Tsutsui, H; Tsutsui, Y; Vandestienne, M; Villa, RE; Wang, P; Watanabe, M; Westendorf, J; Woutersen, R; Xia, J; Xing, W; Xu, X; Yang, L; Yang, N; Yu, J; Yu, M; Yu, X; Zhang, L; Zhao, Y; Zhao, Z; Zhou, X; Zorn, H | 1 |
1 review(s) available for erythrosine and sirolimus
1 trial(s) available for erythrosine and sirolimus
9 other study(ies) available for erythrosine and sirolimus
| Article | Year |
|---|---|
Clonal selection and in vivo quantitation of protein interactions with protein-fragment complementation assays.
Topics: Animals; Carrier Proteins; Cell Survival; CHO Cells; Cricetinae; Erythropoietin; Flow Cytometry; Fluoresceins; Genetic Complementation Test; Immunophilins; Methotrexate; Mice; Microscopy, Fluorescence; Peptides, Cyclic; Phosphotransferases (Alcohol Group Acceptor); Protein Binding; Receptors, Erythropoietin; Recombinant Fusion Proteins; Sirolimus; Tacrolimus; Tacrolimus Binding Proteins; Tetrahydrofolate Dehydrogenase; TOR Serine-Threonine Kinases; Transfection | 1999 |
Effect of immunosuppressants on T-cell subsets observed in vivo using carboxy-fluorescein diacetate succinimidyl ester labeling.
Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Division; Cyclosporine; Fluoresceins; Fluorescent Dyes; Immunosuppressive Agents; Lymphocyte Culture Test, Mixed; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID; Sirolimus; Succinimides; Tacrolimus | 2003 |
Rapamycin-resistant proliferation of CD8+ T cells correlates with p27kip1 down-regulation and bcl-xL induction, and is prevented by an inhibitor of phosphoinositide 3-kinase activity.
Topics: Annexin A5; Antibiotics, Antineoplastic; bcl-X Protein; CD28 Antigens; CD3 Complex; CD8-Positive T-Lymphocytes; Cell Cycle Proteins; Cell Division; Coloring Agents; Cyclin D; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Esters; Fluoresceins; Humans; Kinetics; Lymphocytes; Phosphatidylinositol 3-Kinases; Protein Binding; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Sirolimus; T-Lymphocytes; Time Factors; Tumor Suppressor Proteins | 2004 |
The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy.
Topics: Analysis of Variance; Animals; Bromodeoxyuridine; Cell Death; Disease Models, Animal; Electroencephalography; Epilepsy, Temporal Lobe; Fluoresceins; Gene Expression Regulation; Immunosuppressive Agents; In Situ Nick-End Labeling; Kainic Acid; Male; Mossy Fibers, Hippocampal; Organic Chemicals; Protein Kinases; Rats; Rats, Sprague-Dawley; Seizures; Signal Transduction; Sirolimus; Time Factors; TOR Serine-Threonine Kinases; Video Recording | 2009 |
Rapamycin sensitive ROS formation and Na(+)/H(+) exchanger activity in dendritic cells.
Topics: Animals; Benzoxazoles; Cell Size; Cells, Cultured; Cyclic N-Oxides; Cytosol; Dendritic Cells; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Flow Cytometry; Fluoresceins; Fluorescence; Hydrogen-Ion Concentration; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Reactive Oxygen Species; Sirolimus; Sodium-Hydrogen Exchangers; Spin Labels; tert-Butylhydroperoxide; Triazoles; Tumor Necrosis Factor-alpha | 2012 |
Involvement of PI3K-AKT-mTOR pathway in protein kinase CKII inhibition-mediated senescence in human colon cancer cells.
Topics: Ascorbic Acid; Casein Kinase II; Cellular Senescence; Enzyme Activation; Enzyme Assays; Ethidium; Fluoresceins; Fluorescence; HCT116 Cells; Humans; Hydrogen Peroxide; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Ribosomal Protein S6 Kinases, 70-kDa; RNA Interference; RNA, Small Interfering; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Vitamin E | 2013 |
Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer.
Topics: Adoptive Transfer; Animals; CD4-Positive T-Lymphocytes; Cell Proliferation; Cells, Cultured; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Forkhead Transcription Factors; Half-Life; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Macaca mulatta; Phenotype; Sirolimus; Succinimides; T-Lymphocytes, Regulatory; Tacrolimus; Tissue Distribution; Transplantation, Autologous | 2014 |
Development of an assay for cellular efflux of pharmaceutically active agents and its relevance to understanding drug interactions.
Topics: Antineoplastic Agents, Alkylating; Biological Transport; Busulfan; Cell Line, Tumor; Cell Survival; Chlorambucil; Cyclophosphamide; Drug Interactions; Ethacrynic Acid; Everolimus; Flow Cytometry; Fluoresceins; Humans; Ketoconazole; Melphalan; Multidrug Resistance-Associated Proteins; Reproducibility of Results; Sirolimus | 2017 |
Triggering of Eryptosis, the Suicidal Erythrocyte Death by Mammalian Target of Rapamycin (mTOR) inhibitor Temsirolimus.
Topics: Aniline Compounds; Annexin A5; Antineoplastic Agents; Benzamides; Benzophenanthridines; Calcium; Casein Kinase I; Caspases; Ceramides; Eryptosis; Erythrocytes; Fluoresceins; Gene Expression Regulation; Hemolysis; Humans; Imidazoles; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Phosphatidylserines; Primary Cell Culture; Protein Kinase Inhibitors; Pyridines; Reactive Oxygen Species; Signal Transduction; Sirolimus; Staurosporine; TOR Serine-Threonine Kinases; Xanthenes | 2017 |